The wellness world is eager for RFK Jr.'s promised move on peptides : NPR FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Compounded "semaglutide" is not FDA approved semaglutide.com FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York